Hydroxychloroquine Reduces Mortality by 35% in Hospitalized COVID-19 Patients
This study from Belgium demonstrates that the use of standard/low dose hydroxychloroquine and azithromycin (macrolide) in hospitalized COVID-19 patients reduces the risk of mortality by 35%. Let’s review.
Make a Donation
FLCCC is dedicated to educating as many healthcare providers as possible across the globe and empowering patients with Long COVID or post vaccine injuries to take control of their own health. To help us continue this work, please consider donating to help us cover the costs of these conferences. For other donation options please visit our Donate page!
Share this Lesson
